Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.

Two microbes, christensenella and akkermansia, were especially effective. Dr Spector says these microbes stuck out of the crowd, meaning they were easy to notice for their positive effect.